Literature DB >> 31817219

Surgical Management of Hepatoblastoma and Recent Advances.

Tianyou Yang1,2, Richard S Whitlock1, Sanjeev A Vasudevan1.   

Abstract

Hepatoblastoma is the most common childhood liver malignancy. The management of hepatoblastoma requires multidisciplinary efforts. The five-year overall survival is approximately 80% in developed countries. Surgery remains the mainstay of treatment for hepatoblastoma, and meticulous techniques must be employed to ensure safe and effective local control surgeries. Additionally, there have been several advances from both pediatric and adult literature in the way liver tumor surgery is performed. In this review, we highlight important aspects of liver surgery for hepatoblastoma, the management of metastatic disease, and the most current technical advances in performing these procedures in a safe and effective manner.

Entities:  

Keywords:  children; hepatoblastoma; liver resection; metastasectomy

Year:  2019        PMID: 31817219     DOI: 10.3390/cancers11121944

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  10 in total

1.  Genetic variations in base excision repair pathway genes and risk of hepatoblastoma: a seven-center case-control study.

Authors:  Zhenjian Zhuo; Ao Lin; Jiao Zhang; Huitong Chen; Yong Li; Zhonghua Yang; Li Li; Suhong Li; Jiwen Cheng; Jing He
Journal:  Am J Cancer Res       Date:  2021-03-01       Impact factor: 6.166

2.  Application of 3D Simulation Software in Chemotherapy and Hepatoblastoma Surgery in Children.

Authors:  Jie Liu; Wenli Xiu; Guangqi Duan; Qian Dong
Journal:  Front Surg       Date:  2022-06-01

3.  Laparoscopic caudate lobectomy for large hepatoblastoma in children: A case report.

Authors:  Hoa Viet Nguyen; Trang Thi Huyen Dang; Phuong Ha Tran; Tuan Hong Vu; Quan Quy Hong; Ngoc Bich Nguyen
Journal:  Ann Med Surg (Lond)       Date:  2022-05-13

4.  Outcomes of children with hepatoblastoma who underwent liver resection at a tertiary hospital in China: a retrospective analysis.

Authors:  Jiahao Li; Huixian Li; Huiying Wu; Huilin Niu; Haibo Li; Jing Pan; Jiliang Yang; Tianbao Tan; Chao Hu; Tao Xu; Xiaohong Zhang; Manna Zheng; Kuanrong Li; Yan Zou; Tianyou Yang
Journal:  BMC Pediatr       Date:  2020-05-09       Impact factor: 2.125

5.  Successful management and technical aspects of major liver resection in children: A retrospective cohort study.

Authors:  Kewei Li; Fanwen Jiang; Matthew Aizpuru; Ellen L Larson; Xiaolong Xie; Rongxing Zhou; Bo Xiang
Journal:  Medicine (Baltimore)       Date:  2021-02-12       Impact factor: 1.817

Review 6.  A narrative review of the challenges and countermeasures in hepatoblastoma management during COVID-19 epidemic.

Authors:  Hang Xu; Yan Zhou; Rui Sun; Xuelai Liu; Mei Diao; Xianghai Ren; Long Li
Journal:  Transl Pediatr       Date:  2020-12

7.  Hepatoblastoma: Derived Exosomal LncRNA NEAT1 Induces BMSCs Differentiation into Tumor-Supporting Myofibroblasts via Modulating the miR-132/MMP9 Axis.

Authors:  Yu Hu; Hongyan Zai; Wei Jiang; Zhenglin Ou; Yuanbing Yao; Qin Zhu
Journal:  J Oncol       Date:  2022-03-08       Impact factor: 4.375

8.  Clinical Application of Indocyanine Green Fluorescence Imaging in the Resection of Hepatoblastoma: A Single Institution's Experiences.

Authors:  Yuanchao Shen; Manna Zheng; Jiahao Li; Tianbao Tan; Jiliang Yang; Jing Pan; Chao Hu; Yan Zou; Tianyou Yang
Journal:  Front Surg       Date:  2022-06-30

Review 9.  Molecular Basis of Beckwith-Wiedemann Syndrome Spectrum with Associated Tumors and Consequences for Clinical Practice.

Authors:  Thomas Eggermann; Eamonn R Maher; Christian P Kratz; Dirk Prawitt
Journal:  Cancers (Basel)       Date:  2022-06-23       Impact factor: 6.575

Review 10.  Emerging Role and Mechanism of circRNAs in Pediatric Malignant Solid Tumors.

Authors:  Qiyang Shen; Xingyu Liu; Wei Li; Xu Zhao; Tao Li; Kai Zhou; Jianfeng Zhou
Journal:  Front Genet       Date:  2022-01-18       Impact factor: 4.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.